Should I buy Goosehead Insurance, Inc. (GSHD) stock or is it too late?
⭐ The most reliable of them, either direction: Truist Securities — 72% of its targets hit on this sector (61 calls tested). It aims for $48 (+8.0 %), call made on October 14, 2026, maturing on October 14, 2027 (0 d ago).
Firm-by-firm track record on Goosehead Insurance, Inc.
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| RBC Capital | 50 % | +19.0 % | 14 | $58 +31% |
| B of A Securities | 50 % | +7.3 % | 6 | $37 -17% |
| JMP Securities | 46 % | +1.4 % | 13 | $140 +215% |
| Piper Sandler | 39 % | -7.6 % | 18 | $48 +8% |
| Keefe, Bruyette & Woods | 25 % | -8.6 % | 8 | $66 +49% |
| UBS | 17 % | -21.9 % | 6 | $72 +62% |
✅ Reasons to believe
- Median price target $63, i.e. +42% from the current price ($44).
- The most reliable firm on GSHD, BMO Capital (100% hit rate, 3 scored calls), targets $55 (call made on February 18, 2026, maturing on February 18, 2027) (+24%) in its most recent call, and $79 (call made on November 25, 2025, maturing on November 25, 2026) (+78%) in the one coming due soonest.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 8 ratings, 4 are neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- No dividend: your return depends only on price appreciation.
The analyst consensus on GSHD
Median target $63 (+42%) · 8 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Goosehead Insurance, Inc. now?
We won't decide for you. The facts: 50% of analysts rate it a buy, median target $63 (+42%), and BMO Capital (most reliable on GSHD, 100%) targets $55. Weigh that against valuation. This is not personalized advice.
Is it too late to invest in Goosehead Insurance, Inc.?
Not according to analysts: the median target ($63) is still +42% above the current price ($44) (most reliable on GSHD: BMO Capital, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Goosehead Insurance, Inc. still worth investing in?
It depends on the gap between the price ($44) and its estimated value: analysts target $63 on median (+42%), with 50% buys (most reliable on GSHD: BMO Capital, 100%). Cross-check with their real reliability on GSHD and the cautions above. Information, not advice.
What's the main risk in buying GSHD?
The consensus is not unanimous: of 8 ratings, 4 are neutral.
→ Go deeper: the full Goosehead Insurance, Inc. profile (consensus, analyst reliability, price target, performance).